Nice summary of what we already know from the 1b.
" In contrast to patients in C1 and C2, all patients in C3 mounted substantial HER2-specific Ab levels. Additionally, cellular vaccine responses such as Th1-biased cytokine ratios and reduced Treg numbers were generated. Progression free survival was prolonged in C3, correlating with the vaccine-specific humoral and cellular responses."
PROLONGED.... it works
And its SAFE
Only a few weeks more to wait until we see the PFS data from the phase 2,
I wouldnt be surprised to see it look something like this:
Chemo only patients PFS 5 months.
Chemo plus Her-Vaxx PFS 9 months . With a saftey /side effects profile the big selling mAbs could never envisage.
Pharma partnership deal becomes a foregone conclusion.
The dollar value gets interesting.
Imagine HerVaxx becoming declared the new Standard of Care. Why wouldn't it ???
wake up call....our Mc has yet got a long way to run if this is the case!!!
- Forums
- ASX - By Stock
- IMU
- Ann: Prestigious Research Journal Publish HER-Vaxx Phase 1B Data
Ann: Prestigious Research Journal Publish HER-Vaxx Phase 1B Data, page-17
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.2¢ | 5.3¢ | 5.1¢ | $525.2K | 10.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 92800 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 1045565 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 70000 | 0.052 |
31 | 3304831 | 0.051 |
67 | 5510210 | 0.050 |
18 | 2192645 | 0.049 |
21 | 798435 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 1045565 | 9 |
0.054 | 3292324 | 10 |
0.055 | 791261 | 7 |
0.056 | 2579035 | 12 |
0.057 | 509484 | 7 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online